1-8 of 8
Russ Kuker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of Body Composition Factors and Toxicity in Patients with Advanced Stage Hodgkin Lymphoma Receiving BV-AVD

Michele D. Stanchina, Russ Kuker, Sunwoo Han, Fei Yang, Mark K Polar, Jillian Lorayne Lykon, Tracy Crane, Melissa Lopez-Pentecost, Craig H. Moskowitz, Juan Pablo Alderuccio
Journal: Blood
Blood (2024) 144 (Supplement 1): 4423.
https://doi.org/10.1182/blood-2024-203734
Published: 2024
Journal Articles

Selinexor, Venetoclax, and Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge Study)

Dickran Kazandjian, Kellye Koubek, Andrew Kowalski, Stephanie Mompoint, Rabia Bukhari, Maila Wilson, Jeremy Deni, Sydney Jackson, Yahirini Rodriguez-Martinez, Justin Llano, Michelle Armogan, Stephanie Fernandes, Maurizio Affer, Sana Chaudhry, Tulasigeri M Totiger, Catalina Amador, Melinda Boone, Jennifer Rose Chapman-Fredricks, Mike Georgiou, Russ Kuker, Katie Thoren, Yi Zhou, David G. Coffey, Marcella Kaddoura, Francesco Maura, Benjamin Diamond, James Edward Hoffman, Justin Taylor, Ola Landgren
Journal: Blood
Blood (2024) 144 (Supplement 1): 7049.
https://doi.org/10.1182/blood-2024-193966
Published: 2024
Journal Articles

Loncastuximab Tesirine with Rituximab Induces Robust and Durable Complete Metabolic Responses in High-Risk Relapsed/Refractory Follicular Lymphoma

Juan Pablo Alderuccio, Alvaro J Alencar, Jonathan H. Schatz, Russ Kuker, David Sicre, Georgios Pongas, Isildinha M. Reis, Jay Y. Spiegel, Laura Medina Andara, Lazaros J. Lekakis, Joseph S. Gyedu, Jose Sandoval-Sus, Amer M. Beitinjaneh, Michele D. Stanchina, Asaad Trabolsi, Izidore S. Lossos, Joseph D. Rosenblatt, David S. Lessen, Craig H. Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 337.
https://doi.org/10.1182/blood-2024-199093
Published: 2024
Journal Articles

Limited Duration Loncastuximab Tesirine Induces a High Rate of Complete Responses in Patients with Relapsed/Refractory Marginal Zone Lymphoma - Report of First Planned Interim Futility Analysis of a Multicenter Phase II Study

Izidore S. Lossos, Geoffrey Shouse, Alvaro J Alencar, Safia Sawleh, David S. Lessen, Craig H. Moskowitz, Jennifer Rose Chapman-Fredricks, Isildinha M. Reis, Russ Kuker, Juan Pablo Alderuccio
Journal: Blood
Blood (2024) 144 (Supplement 1): 3032.
https://doi.org/10.1182/blood-2024-200205
Published: 2024
Journal Articles

Epcoritamab with R-CHOP Overcomes Poor Risk Features of High Total Metabolic Tumor Volume in High-Risk Large B-Cell Lymphoma

Juan Pablo Alderuccio, Russ Kuker, Mark K Polar, Fei Yang, Craig H. Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1622.
https://doi.org/10.1182/blood-2024-209334
Published: 2024
Journal Articles

Limited Duration Loncastuximab Tesirine with Rituximab Induces High Complete Metabolic Response Rate in High-Risk Relapsed/Refractory Follicular Lymphoma - a Phase 2 Study

Juan Pablo Alderuccio, Alvaro J. Alencar, Jonathan H. Schatz, Russ Kuker, Georgio Pongas, Isildinha M. Reis, Jay Y. Spiegel, Laura Medina Andara, Lazaros J. Lekakis, Joseph S. Gyedu, Jose Sandoval-Sus, Amer M. Beitinjaneh, Nathalie Padron, Izidore S. Lossos, Joseph D. Rosenblatt, David S. Lessen, Craig H. Moskowitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 984.
https://doi.org/10.1182/blood-2023-178825
Published: 2023
Journal Articles

PET/CT Enables Appropriate Staging in Extranodal Marginal Zone Lymphoma

Juan Pablo Alderuccio, Michele D. Stanchina, Jean L. Koff, Isildinha M. Reis, Eduardo Edelman Saul, Melissa C. Larson, Dai Chihara, Wei Zhao, Thomas M. Habermann, Peter Martin, Loretta J. Nastoupil, Jennifer R. Chapman-Fredricks, Andrew L. Feldman, Brian K. Link, Brad S. Kahl, Jonathon B. Cohen, Mark K Polar, Rafael Henneman Sassi, Craig H. Moskowitz, Jonathan W. Friedberg, James R. Cerhan, Russ Kuker, Christopher R. Flowers, Izidore S. Lossos
Journal: Blood
Blood (2023) 142 (Supplement 1): 5134.
https://doi.org/10.1182/blood-2023-179478
Published: 2023
Journal Articles

Selinexor, Venetoclax, and Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge Study)

Dickran Kazandjian, Justin Taylor, Kellye Koubek, Rabia Bukhari, Maila Wilson, Isabella Schiwy, Yahirini Rodriguez-Martinez, Justin Llano, Stephanie Fernandes, Michelle Armogan, Maurizio Affer, Sana Chaudhry, Tulasigeri M Totiger, Catalina Amador, Melinda Boone, Jennifer R. Chapman-Fredricks, Mike Georgiou, Russ Kuker, Katie Thoren, Yi Zhou, Benjamin Diamond, James E. Hoffman, Ola Landgren
Journal: Blood
Blood (2023) 142 (Supplement 1): 6740.
https://doi.org/10.1182/blood-2023-180939
Published: 2023